Phospho-RELB (S552) Antibody

What is Phospho-RELB (S552) Antibody and what does it specifically detect?

Phospho-RELB (S552) Antibody is a specialized immunological reagent designed to detect endogenous levels of the RELB protein specifically when phosphorylated at serine residue 552 . RELB is a critical member of the NF-κB family of transcription factors that regulate genes involved in inflammation, immunity, cell differentiation, and apoptosis. This antibody recognizes the unique conformational change that occurs when the serine residue at position 552 in the RELB protein undergoes phosphorylation, enabling researchers to study this specific post-translational modification in various experimental contexts .

What is the biological significance of RELB phosphorylation at Ser552?

Phosphorylation of RELB at Ser552 plays a crucial regulatory role in NF-κB signaling by targeting RELB for proteasomal degradation . This represents an important negative regulatory mechanism within the NF-κB pathway. GSK3B has been identified as the kinase responsible for catalyzing this phosphorylation at Ser552 . Research indicates that this post-translational modification, along with phosphorylation at Thr84, triggers the degradation process, thereby modulating RELB-dependent transcriptional activity and downstream cellular responses . This phosphorylation-dependent regulation contributes to the tight control of inflammatory responses and immune cell function.

Commercial Phospho-RELB (S552) antibodies have demonstrated confirmed reactivity with human and mouse samples . This cross-species reactivity is based on the high sequence homology in the region surrounding the Ser552 phosphorylation site. While some antibodies may potentially cross-react with additional species that share 100% sequence homology in the epitope region, this reactivity may not have been experimentally validated by manufacturers and should be empirically tested by researchers working with those species .

How should samples be prepared to preserve RELB Ser552 phosphorylation status?

For accurate detection of Phospho-RELB (S552), proper sample preparation is critical:

• Cells or tissues should be lysed in buffer containing phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate, β-glycerophosphate) to prevent dephosphorylation during sample processing .

• Maintain samples at 4°C throughout processing to minimize phosphatase activity.

• For Western blotting applications, use freshly prepared samples whenever possible, as freeze-thaw cycles can affect phosphorylation status.

• For immunohistochemistry, tissues should be rapidly fixed (preferably in phosphate-buffered 4% paraformaldehyde) to preserve phosphorylation state .

• When stimulating cells to induce RELB phosphorylation, consider timing carefully as phosphorylation at Ser552 can lead to rapid degradation of RELB protein .

What positive controls should be used to validate Phospho-RELB (S552) Antibody specificity?

To confirm antibody specificity:

• Use cell lysates from TPA-ionomycin-stimulated T cells, which have been demonstrated to induce RELB phosphorylation at Ser552 .

• Include a phosphatase-treated sample as a negative control to confirm phospho-specificity.

• When possible, include samples from RELB-knockout or RELB-deficient cells reconstituted with either wild-type RELB or RELB-S552A mutant (which cannot be phosphorylated at this position) .

• Compare results with a total RELB antibody to assess the relationship between phosphorylated and total protein levels.

• For genetic validation, expression of a phospho-mimetic mutant (S552E or S552D) can serve as a positive control for antibody binding specificity.

What are the optimal cell stimulation conditions to induce RELB Ser552 phosphorylation?

Several stimulation conditions have been reported to induce RELB Ser552 phosphorylation:

• TPA-ionomycin treatment in T cells has been demonstrated to induce Ser552 phosphorylation .

• Activation of GSK3B, which catalyzes the phosphorylation of RELB at Ser552, can be achieved through various signaling pathways .

• While TNFα treatment (at least 6 hours) induces RELB nuclear accumulation in fibroblasts , its specific effect on Ser552 phosphorylation should be empirically determined in each experimental system.

• Proteasome inhibitors (such as MG132) may be useful for accumulating phosphorylated RELB at Ser552, as this modification triggers proteasomal degradation .

How does phosphorylation at Ser552 regulate RELB function compared to other phosphorylation sites?

RELB undergoes phosphorylation at multiple sites, each with distinct functional consequences:

These differential phosphorylation patterns allow for context-specific regulation of RELB function across different cell types and stimuli. While Ser552 phosphorylation represents a negative regulatory mechanism leading to degradation, Ser472 phosphorylation appears to enhance specific RELB transcriptional activities related to cell migration .

How can Phospho-RELB (S552) Antibody be used to study non-canonical NF-κB signaling dynamics?

Studying non-canonical NF-κB signaling using Phospho-RELB (S552) Antibody can be approached through several experimental strategies:

• Time-course experiments following stimulation with non-canonical pathway activators (e.g., lymphotoxin β, CD40L, BAFF) to monitor changes in RELB phosphorylation status.

• Co-immunoprecipitation studies to identify proteins that interact specifically with phosphorylated RELB at Ser552 versus non-phosphorylated RELB.

• Chromatin immunoprecipitation (ChIP) assays to determine whether Ser552 phosphorylation affects RELB binding to specific promoter regions.

• Dual immunofluorescence or proximity ligation assays to visualize co-localization of phosphorylated RELB with other NF-κB subunits (p50, p52) under various stimulation conditions.

• Paired analysis with phospho-specific antibodies against other pathway components (e.g., NIK, IKKα, p100/p52) to establish the relationship between RELB Ser552 phosphorylation and other events in non-canonical signaling.

What are the mechanistic implications of RELB Ser552 phosphorylation in inflammatory disease models?

RELB plays critical roles in inflammatory responses, as evidenced by the significant impairment of these responses in RELB-null mice . The phosphorylation of RELB at Ser552, which leads to its degradation, may represent an important regulatory checkpoint in inflammatory conditions:

• In chronic inflammatory diseases, dysregulation of GSK3B activity could potentially lead to altered RELB Ser552 phosphorylation patterns, affecting the balance of inflammatory responses.

• The degradation of RELB following Ser552 phosphorylation may serve as a negative feedback mechanism to limit excessive inflammatory signaling.

• In the context of the NUPR1/RELB/IER3 survival pathway, RELB has been identified as providing pancreatic ductal adenocarcinoma with resistance to cell stress conditions , suggesting that modulation of RELB phosphorylation could impact cancer cell survival under therapeutic intervention.

• Given that RELB regulates genes involved in hematopoietic differentiation , alterations in its phosphorylation status could affect immune cell development in inflammatory disease contexts.

How can multiplexed detection methods be used to study RELB Ser552 phosphorylation in relation to other signaling events?

Advanced multiplexed approaches can provide deeper insights into the relationship between RELB Ser552 phosphorylation and other signaling events:

• Multiplex flow cytometry using Phospho-RELB (Ser552) antibody conjugated to FITC alongside antibodies against other phosphorylated proteins in the NF-κB pathway.

• Sequential immunoprecipitation to isolate different pools of RELB based on their phosphorylation status at various sites.

• Mass spectrometry-based phosphoproteomic analysis to quantitatively assess multiple phosphorylation sites on RELB simultaneously and identify novel modification patterns.

• Single-cell resolution imaging techniques, such as imaging mass cytometry or multiplexed ion beam imaging, to visualize the spatial distribution of phosphorylated RELB in heterogeneous tissue samples.

• Proximity-dependent biotinylation (BioID or TurboID) using RELB as bait to identify proteins that specifically interact with RELB when phosphorylated at Ser552.

How can researchers troubleshoot weak or inconsistent signals when using Phospho-RELB (S552) Antibody?

When encountering detection challenges with Phospho-RELB (S552) Antibody, consider these troubleshooting approaches:

• Ensure complete phosphatase inhibition during sample preparation by using fresh inhibitor cocktails and maintaining cold temperatures throughout processing.

• Optimize antibody concentration and incubation conditions. For Western blotting, try longer primary antibody incubation (overnight at 4°C) and consider blocking with 5% BSA instead of milk proteins, which may contain phosphatases.

• For immunoprecipitation applications, increase the amount of starting material, as phosphorylated RELB represents only a fraction of total RELB protein.

• Verify that your stimulation conditions effectively induce Ser552 phosphorylation in your specific cell type, as pathway activation can vary significantly between different cellular contexts.

• If detecting phosphorylated RELB by Western blot, consider using gradient gels (4-12%) to achieve better resolution of the approximately 70 kDa band .

• Remember that phosphorylation at Ser552 triggers degradation of RELB; therefore, including proteasome inhibitors in your experimental design may enhance detection by preventing degradation of the phosphorylated protein.

What are the key considerations when validating research findings using Phospho-RELB (S552) Antibody?

To ensure robust and reproducible results:

• Confirm antibody specificity using multiple approaches, including phosphatase treatment, RELB knockdown/knockout controls, and competition with phospho-peptides.

• Validate findings using complementary techniques (e.g., if identified by Western blot, confirm with immunofluorescence or mass spectrometry).

• Use site-directed mutagenesis (S552A or S552E/D) to confirm the functional significance of this specific phosphorylation site.

• Include physiologically relevant positive controls in each experiment to ensure the detection system is working properly.

• Consider that different antibody clones may have varying specificities and sensitivities; when possible, confirm key findings with a second Phospho-RELB (S552) antibody from a different source or clone.

• For quantitative applications, establish a dynamic range for the assay and ensure that measurements fall within the linear range of detection.

How might RELB Ser552 phosphorylation contribute to cell-type specific transcriptional programs?

RELB forms heterodimers with either p50 or p52 NF-κB subunits to regulate transcription , but the impact of Ser552 phosphorylation on these interactions and subsequent transcriptional outcomes may vary by cell type:

• In fibroblasts, RELB's role in migration appears to be regulated by phosphorylation at Ser472 rather than Ser552 , suggesting that different phosphorylation sites may dominate in different cellular contexts.

• In T cells, TPA-ionomycin-induced phosphorylation at Ser552 leads to degradation , potentially affecting T cell activation and cytokine production programs.

• Research indicates that RELB may provide pancreatic ductal adenocarcinoma with resistance to cell stress , suggesting a potential role in cancer-specific transcriptional programs that could be modulated by phosphorylation status.

• The interaction between phosphorylated RELB and other transcription factors or coactivators might differ across cell types, leading to cell-specific gene expression patterns even when the same signaling pathway is activated.

What is the relationship between RELB phosphorylation at Ser552 and other post-translational modifications?

RELB function is likely regulated by a complex interplay of multiple post-translational modifications:

• While phosphorylation at Ser552 and Thr84 appears to promote degradation , it remains unclear whether these modifications occur sequentially or in tandem, and whether they might affect other types of modifications.

• NF-κB signaling involves numerous ubiquitination events, but the relationship between Ser552 phosphorylation and potential ubiquitination of RELB has not been fully characterized in the provided research.

• The kinetics of different modifications may create temporal windows for specific RELB functions before degradation is triggered by Ser552 phosphorylation.

• Research into the "modification code" of RELB could reveal how various combinations of post-translational modifications determine specific functional outcomes in different cellular contexts.

• Advanced proteomic approaches will be necessary to comprehensively map the interdependencies between different modifications on RELB and their collective impact on protein function.